Ethel S. Siris

Active 1976–2024

Also published as
ETHEL S. SIRIS
85
Papers
24,173
Citations
79
h-index
85
i10-index

Citations

Citations per year for Ethel S. Siris1977: 1 citations1978: 4 citations1980: 3 citations1981: 9 citations1982: 13 citations1983: 9 citations1985: 8 citations1986: 7 citations1987: 9 citations1988: 9 citations1989: 6 citations1990: 8 citations1991: 17 citations1992: 22 citations1993: 15 citations1994: 10 citations1995: 17 citations1996: 36 citations1997: 21 citations1998: 39 citations1999: 53 citations2000: 50 citations2001: 44 citations2002: 59 citations2003: 71 citations2004: 80 citations2005: 108 citations2006: 146 citations2007: 107 citations2008: 162 citations2009: 140 citations2010: 185 citations2011: 176 citations2012: 192 citations2013: 199 citations2014: 159 citations2015: 182 citations2016: 150 citations2017: 160 citations2018: 146 citations2019: 492 citations2020: 546 citations2021: 369 citations2022: 330 citations2023: 281 citations2024: 525 citations2025: 225 citations2026: 12 citations1979: no citations, so this year is not shown1984: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,908 citing papers, 24.8% of this breakdownUnited Kingdom: 682 citing papers, 8.9% of this breakdownChina: 510 citing papers, 6.6% of this breakdownCanada: 423 citing papers, 5.5% of this breakdownAustralia: 346 citing papers, 4.5% of this breakdownItaly: 330 citing papers, 4.3% of this breakdownFrance: 274 citing papers, 3.6% of this breakdownSwitzerland: 252 citing papers, 3.3% of this breakdownGermany: 251 citing papers, 3.3% of this breakdownBelgium: 230 citing papers, 3% of this breakdownNetherlands: 216 citing papers, 2.8% of this breakdownSpain: 191 citing papers, 2.5% of this breakdown
0%24.8%Other 26.9%

Fields

  • Medicine83.5%
  • Biochemistry, Genetics and Molecular Biology10.7%
  • Engineering1.4%
  • Health Professions0.8%
  • Immunology and Microbiology0.5%
  • Environmental Science0.5%
  • Other2.6%

Topics

  • Bone health and osteoporosis research20.7%
  • Bone health and treatments10.5%
  • Bone Metabolism and Diseases7.7%
  • Hip and Femur Fractures6%
  • Parathyroid Disorders and Treatments4.7%
  • Bone and Joint Diseases4.1%
  • Other46.3%

Coauthors

All papers

Open in search
  1. The clinician’s guide to prevention and treatment of osteoporosis

    Authors: , , , , , , - Osteoporosis International 2022 cited by 1,339

  2. Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 3,442

  3. The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group

    Authors: , , , , , , , , , , , , , , , - Osteoporosis International 2014 cited by 663

  4. Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent Fractures

    Authors: , , , , , , - Archives of Internal Medicine 2004 cited by 1,083

  5. Obesity Is Not Protective against Fracture in Postmenopausal Women: GLOW

    Authors: , , , , , , , , , , , , , , , , , , , , - The American Journal of Medicine 2011 cited by 551

  6. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis

    Authors: , , , , , , , , , , , , - Journal of Bone and Mineral Research 2010 cited by 247

  7. Identification and Fracture Outcomes of Undiagnosed Low Bone Mineral Density in Postmenopausal Women

    Authors: , , , , , , , , - JAMA 2001 cited by 1,220

  8. Hip fracture trends in the United States, 2002 to 2015

    Authors: , , , , , , , , - Osteoporosis International 2017 cited by 279

  9. Biomechanical Computed Tomography analysis (BCT) for clinical assessment of osteoporosis

    Authors: , , , , , , - Osteoporosis International 2020 cited by 133

  10. Osteoporosis and Fracture Risk in Women of Different Ethnic Groups

    Authors: , , , , , , , - Journal of Bone and Mineral Research 2005 cited by 557

  11. Relationship of Weight, Height, and Body Mass Index With Fracture Risk at Different Sites in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women (GLOW)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Bone and Mineral Research 2013 cited by 267

  12. A 10-Year Prospective Study of Primary Hyperparathyroidism with or without Parathyroid Surgery

    Authors: , , , , - New England Journal of Medicine 1999 cited by 831

  13. Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention

    Authors: , , , , , , , , , , - Journal of Bone and Mineral Research 2012 cited by 382

  14. Previous fractures at multiple sites increase the risk for subsequent fractures: The global longitudinal study of osteoporosis in women

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Bone and Mineral Research 2011 cited by 184

  15. Osteoporosis and Hip Fracture Risk From Routine Computed Tomography Scans: The Fracture, Osteoporosis, and CT Utilization Study (FOCUS)

    Authors: , , , , , , , , , , - Journal of Bone and Mineral Research 2018 cited by 116

  16. The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA

    Authors: , , , , - Osteoporosis International 2016 cited by 132

  17. The Natural History of Primary Hyperparathyroidism with or without Parathyroid Surgery after 15 Years

    Authors: , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2008 cited by 587

  18. Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed

    Authors: , , , , , , , , , - Bone 2020 cited by 28

  19. Enhanced prediction of fracture risk combining vertebral fracture status and BMD

    Authors: , , , , , - Osteoporosis International 2007 cited by 196

  20. Performance of Risk Indices for Identifying Low Bone Density in Postmenopausal Women

    Authors: , , , , , , , , , - Mayo Clinic Proceedings 2002 cited by 153

  21. Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Bone 2012 cited by 149

  22. Osteoporosis-associated Fracture and Diabetes

    Authors: , , - Endocrinology and Metabolism Clinics of North America 2013 cited by 122

  23. The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50–99: results from the National Osteoporosis Risk Assessment (NORA)

    Authors: , , , , , , - Osteoporosis International 2006 cited by 269

  24. ZNF687 Mutations in Severe Paget Disease of Bone Associated with Giant Cell Tumor

    Authors: , , , , , , , , , , , , , , , , - The American Journal of Human Genetics 2016 cited by 81